and cell-free DNA (cfDNA) that support efforts to find solutions and cures by the scientific community for Clinical Diagnosis, Lifesciences and Research.
are the cornerstones of PM's corporate DNA.
of therapeutic antibodies are made using recombinant DNA technology, which has enabled the engineering of specific functions and the reduction or elimination
to support isothermal amplification of DNA and RNA. The market pull for this venture came from the growing demands around the world for field testing,